Predictive Factors for Survival in Aggressive Meningiomas
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
About this trial
The investigators plan to collect clinical and molecular data, including ICH, PCR, NGS and methylome, from patients operated on for grade 2 or grade 3 meningioma. The purpose of the study is to identify reliable and easy-to-assess predictive factors for recurrence and survival after surgery.
Eligibility criteria
Qualifiers
Patient operated for atypical (grade 2) meningioma; or
Patient operated for anaplastic (grade 3) meningioma;
Timeframe for surgery, 1999-2019
Disqualifiers
None
Trial design
Treatments tested in this trial
- Biological biomarker assessment
Treatment groups
250 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov